InvestorsHub Logo

Hike

10/31/14 3:43 PM

#132685 RE: dr_lowenstein #132684

Indeed.

But $210,000,000 is quite achievable.
I'm only counting US, not Canada or Europe
I'm only assuming 30% of Opioid market to be ARTs/ADT's
I'm only assuming 10% market share of the ART/ADT market in the US.

...and even with all of that we have a 50 fold increase in sales.

What would that do to the share price?